Search results
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 14 hours agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Stock market update: Nifty Pharma index advances 0.14%
The Economic Times· 14 hours agoThe Nifty Pharma index closed 0.14 per cent up at 19786.4.
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 18 hours agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
Indians More Willing to Spend on Health Post-Covid; Demand for Wellness Packages Up: Metropolis...
News18· 21 hours agoIndians are driving a surge in demand for health and wellness check-ups, reflecting an increase in...
Promoters stake sale hit $10.5 billion in first half of 2024 - CNBC TV18
CNBC TV18· 2 days agoPromoters of 37 companies offloaded as much as $10.5 billion worth of shares in the first six months...
Indus Towers, Vedanta, IndiGo, Polycab, Bharti Airtel: Why are promoters selling shares?
Business Today· 2 days agoIndus Towers Ltd, Vedanta Ltd, Interglobe Aviation Ltd (IndiGo), Polycab and Bharti Airtel Ltd are some of the companies, where promoters sold stakes recently.
Mankind Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
CNBC Awaaz· 2 days agoMankind Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 2 days agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Stocks to Buy: ICICI Bank, SBI, L&T among top 26 bottom up picks by Jefferies
Livemint· 5 days agoCheck details
Emcure Pharmaceuticals' IPO to open on July 3rd | India Infoline
India Infoline· 5 days agoPune-based Emcure Pharmaceuticals is gearing up to launch its maiden public issue for subscription on July 3. The company has set a price band of ₹960-1008 per share for its initial public offering ...